Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: European Pharmacopoeia Commission | Statement: [European Pharmacopoeia, hasGoverningBody, European Pharmacopoeia Commission]

Target entity: European Pharmacopoeia Commission
Context triple: [European Pharmacopoeia, hasGoverningBody, European Pharmacopoeia Commission]

• A. European Pharmacopoeia
  The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
• B. Committee for Herbal Medicinal Products
  The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
• C. European Union Drugs Agency
  The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
• D. European Medicines Agency
  The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
• E. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: European Pharmacopoeia Commission
Triple: [European Pharmacopoeia, hasGoverningBody, European Pharmacopoeia Commission]

The European Pharmacopoeia Commission is the decision-making body responsible for developing and adopting official quality standards for medicines and their ingredients across member states of the Council of Europe.

Target entity: European Pharmacopoeia Commission
Target entity description: The European Pharmacopoeia Commission is the decision-making body responsible for developing and adopting official quality standards for medicines and their ingredients across member states of the Council of Europe.

• A. European Pharmacopoeia chosen
  The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
• B. Committee for Herbal Medicinal Products
  The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
• C. European Union Drugs Agency
  The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
• D. European Medicines Agency
  The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
• E. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• F. None of above.